Inflammatory Bowel Disease

IBD Associated with Increased risk of Autoimmune and Inflammatory Diseases

A registry based study has shown higher rates of…
rheumnow.com

The JAK-STAT Pathway in Inflammatory Bowel Disease

Russell D. Cohen, MD, and Thomas A. Ullman, MD, summarize clinical data on JAK inhibitors in inflammatory bowel disease (IBD). In addition to discussing the rationale for targeting JAK-STAT…
annenberg.net

US FDA accepts Pfizer’s sNDA for Xeljanz to treat ulcerative colitis

The US Food and Drug Administration (FDA) has accepted for filing Pfizer’s supplemental New Drug Application (sNDA) for Xeljanz (tofacitinib citrate), an…
pharmaceutical-technology.com

No Comments Yet.

Leave a comment